Yttrium-90 Radioembolization Neoadjuvant Therapy With Immune Marker Profiling and Dosimetry for Potentially Resectable Patients With Colorectal Liver Metastases

NCT07406126 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Liver Metastases (CRCLM)
Unresectable Colorectal Liver Metastases

Interventions

PROCEDURE: Yttrium-90 Radioembolization with standard systemic therapy

Sponsor

Fernando Gómez Muñoz

Collaborators

[object Object]
[object Object]